January 1, 2010
Below is an excerpt from CSOFT’s President and CEO Shunee Yee’s article in ClientSide News.
“In spite of the downward economy and in spite of the slashed budgets and lost jobs that are afflicting no small number of previously healthy companies everywhere, at CSOFT we have been fortunate enough to experience considerable organic growth in 2009. This isn’t intended as a provocation to those who have struggled in the past couple of years. Rather, my intention is to say, there’s hope out there. We’re in this mess too, but we’re surviving—and so can you.”
About CSOFT Health Sciences
CSOFT Health Sciences, leaders in clinical trial localization, provides AI/ML-enabled medical translation services for all phases of the drug and medical device product lifecycle, from development to post-launch. We also specialize in DCT solutions, linguistic validation, and CTD/eCTD submissions with the FDA, EMA, and NMPA. Our operations are certified in ISO 17100:2015, ISO 9001:2015, and ISO 13485:2016, ensuring our customized solutions meet the rigorous regulatory requirements of MMA, NDA, CTA, and Medical Device Application submissions. www.csoftintl.com
